The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2023 | R2-ISS in newly diagnosed multiple myeloma: real-world experience
Jelena Bila, MD, PhD, University of Belgrade, Belgrade, Serbia, discusses the use of the second revision of the International Staging System (R2-ISS) in patients with newly diagnosed multiple myeloma (NDMM) in the real-world setting. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
